Veracyte (VCYT) Stock Forecast & Price Target

VCYT$24.33-0.30 -1.22%
Medical - Diagnostics & ResearchGrowth StockHigh Quality
Compare
Market cap$1.96BEnterprise value$1.77BRevenue (TTM)$581.78MMarket position—

Score

65
Bullish
Value
44
Quality
79
Growth
71

Veracyte, Inc. price target

VCYT
Low$44.00
Average$54.14
High$65.00
Upside vs current price+122.5%

The average target of $54.14 is +122.5% versus the current VCYT price of $24.33.

Veracyte, Inc. analyst ratings

RatingAnalysts
Strong buy2
Buy9
Hold1
Sell0
Strong sell0
ConsensusBuy

12 analysts cover VCYT.

Veracyte, Inc. EPS and revenue estimates

Published annual figures for VCYT on this page are 2026 EPS $1.91, 2027 EPS $1.94. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$1.91$593.82M
2027$1.94$660.03M

Is Veracyte, Inc. a buy or sell?

Of the 12 analysts covering Veracyte, Inc., 11 rate it a buy (2 strong buy and 9 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The VCYT consensus label is Buy, beside 11 buy-side ratings and 0 sell-side ratings.

The average target of $54.14 implies +122.5% versus the current price of $24.33.

The VCYT rating block is 12 published views with a Buy label. It does not tell you whether to buy or sell.

Reading the Veracyte, Inc. forecast

the Veracyte, Inc. is priced by the street between $44.00 and $65.00, average $54.14.

The gap from the $24.33 price to the VCYT average is +122.5%.

The VCYT rating mix is lopsided rather than split: 11 of 12 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.

The latest VCYT actions do not point one way: 0 up and 1 down.

The recent VCYT average ($46.00) is under the quarterly figure ($55.50).

With 12 analysts on VCYT, the average is a small sample.

Veracyte, Inc. forecast questions

What is the VCYT price target?

The published range for VCYT is $44.00 to $65.00, with an average of $54.14. That average is +122.5% versus the current price of $24.33.

Is Veracyte, Inc. a buy or sell?

Of the 12 analysts covering Veracyte, Inc., 11 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, leaving VCYT at 11 buy ratings, 1 holds, and 0 sells.

What is the EPS estimate for Veracyte, Inc.?

Analyst EPS estimates for Veracyte, Inc.: 2026 $1.91, 2027 $1.94.

What is the revenue estimate for Veracyte, Inc.?

Analyst revenue estimates for Veracyte, Inc.: 2026 $593.82M, 2027 $660.03M.

How many analysts cover VCYT?

12 analysts cover VCYT. Their consensus on VCYT is Buy, across those 12.

VCYT price $24.33 -0.30 -1.22%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener